Clinical features and prognosis of patients with novel coronavirus pneumonia complicated with diabetes
Ji Ye-Long,Wu Yang,Leng Yan,Zhang Yi,Zhang Ai-Ning,Xia Zhong-Yuan
2020-01-01
Abstract:Objective: To analyze the clinical characteristics and laboratory examinations of patients with new coronavirus (COVID-19) and compare the effect and prognosis of patients with diabetes mellitus (DM) on COVID-19.Methods: 56 cases of COVID-19 with DM and 85 age-matched admitted patients without DM who were admitted to the People's Hospital of Wuhan University from January 31, 2020 to March 15, 2020 were analyzed through a retrospective cohort study. Patients data were collected through electronic cases, and used SPSS 26.0 and Graphpad Prism 8.0 statistical software to compare changes in various indicators of patients in DM and non-DM groups and to draw the survival curves.Results: Compared with the non-DM group, the DM group has a higher percentage of mechanical ventilation, higher mortality and severe patients, with a higher proportion of initial symptoms of nausea and hypertension (P <0.05). There were no significant differences in the gender, initial symptoms (except nausea), the combined underlying diseases (except hypertension) between the two groups (P <0.05); The white blood cell, centroblast count, CRP, PCT, PT, D-dimer, total bilirubin, Urea, LDH, CK, MB, hs-TnI, CK-MB, NT-proBNP were higher in the DM group (P <0.05), and lymphocytes, single Nuclear cell, CD3, CD4, and CD8 counts were low (P <0.05). There was no statistically significant difference in platelet, IL-6, APTT, ALT, AST, Cr and CD19 counts between the two groups.Conclusion: Compared with COVID-19 patients with non-DM, COVID-19 patients with DM have a higher proportion of mortality and severe cases. Heart function, liver and kidney function, immune function damage and coagulation dysfunction are more obvious. Therefore, the monitoring of such patients should be strengthened, and active treatment should be performed to improve the prognosis.